Skye Bioscience has been included in the Russell 2000 Index and the broad-market Russell 3000 Index, effective at the U.S. market open on July 1, 2024, as part of the annual reconstitution of the Russell stock indexes.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKYE:
- Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes
- Skye BioScience Participating in Piper Sandler Virtual Obesity Day
- Skye Bioscience financial well-positioned into 2027, says Oppenheimer
- Skye Bioscience Files Current SEC Report
- Skye Bioscience focuses clinical development on nimacimab metabolic program